Bank of New York Mellon Corp

Bank

Position in VSTM — Verastem, Inc.

CIK 1390777 NEW YORK, NY

Position in VSTM

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$857,045

-$90,112 QoQ

Shares Held

161,707

+31.8% QoQ

Ownership

0.184%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 93.35526600580062.ToString("F0")% Shared 0.ToString("F0")% None 6.6447339941993855.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. VSTM ranks #181 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,586,427	$708,403,098
2	REGN	Regeneron Pharmaceuticals, Inc.	765,411	$591,387,145
3	JAZZ	Jazz Pharmaceuticals plc	1,679,371	$317,485,079
4	INSM	INSMED Inc	1,262,749	$206,484,708
5	ALNY	Alnylam Pharmaceuticals, Inc.	491,200	$162,523,337
6	INCY	Incyte Corp	989,709	$93,151,403
7	TECH	BIO-TECHNE Corp	1,759,119	$91,931,549
8	MRNA	Moderna, Inc.	1,691,205	$85,913,207

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$857,045	161,707	+31.8%	Shares	Defined	2026-05-05
2025-12-31	$947,157	122,689	+7.3%	Shares	Defined	2026-02-10
2025-09-30	$1,009,435	114,319	+8.5%	Shares	Defined	2025-11-03
2025-06-30	$437,426	105,404	+19.9%	Shares	Defined	2025-08-05
2025-03-31	$530,030	87,899	-0.6%	Shares	Defined	2025-04-29
2024-12-31	$457,151	88,424	+12.0%	Shares	Defined	2025-02-04
2024-09-30	$235,971	78,921	+15.7%	Shares	Defined	2024-11-12
2024-06-30	$203,306	68,224	+493.3%	Shares	Defined	2024-07-25
2023-12-31	$93,601	11,499	-49.5%	Shares	Defined	2024-01-29
2023-09-30	$185,022	22,758	+27.7%	Shares	Defined	2023-10-24
2023-06-30	$132,573	17,819	—	Shares	Defined	2023-08-03
No filing history on record for this holder in this stock.